HuGE Literature Finder
Records
1
-
19
| Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. Cancer medicine 2022 Jun . Tian Hong-Xia, Chen Zhi-Hong, Jie Guang-Ling, Wang Zhen, Yan Hong-Hong, Wu Si-Pei, Zhang Shui-Lian, Lu Dan-Xia, Zhang Xu-Chao, Wu Yi-Lo |
| Evaluation of the Mutation Profile via Next-Generation Sequencing in a Turkish Population With Non-small Cell Lung Cancer. Balkan medical journal 2021 Nov 38 (6): 382-391. Kahraman Çetin Nesibe, Erdo?du ?brahim Halil, Bozkurt Emin, Meteo?lu ?brah |
| NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421. Li X, Yu J, Wang |
| Mutational status of main driver genes influences the prognosis of stage I-III lung adenocarcinoma patients underwent radical surgery. Translational cancer research 2021 Jul 10 (7): 3286-3298. Liao Hongliang, Luo Xiaoyan, Liang Yaqin, Wan Renping, Xu Me |
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
| Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey. BMC cancer 2020 Oct 20 (1): 994. Sun Peng, Li Yue, Chao Xue, Li Jibin, Luo Rongzhen, Li Mei, He Jieh |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian). Journal of thoracic disease 2020 Jul 12 (7): 3776-3784. Izumi Motohiro, Suzumura Tomohiro, Ogawa Koichi, Matsumoto Yoshiya, Sawa Kenji, Yoshimoto Naoki, Tani Yoko, Watanabe Tetsuya, Kaneda Hiroyasu, Mitsuoka Shigeki, Asai Kazuhisa, Kawaguchi Tomo |
| Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations. Cancer biomarkers : section A of Disease markers 2020 Feb . Geng Hua, Li Shixiong, Guo Yixian, Yan Fang, Han Yuebin, Xu Meilin, Cui Yanz |
| Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients. OncoTargets and therapy 2020 13 9525-9531. Wei Weitian, Li Xingliang, Song Mengmeng, Wang Changch |
| Co-occurring genetic alterations predict distant metastasis and poor efficacy of first-line EGFR-TKIs in EGFR-mutant NSCLC. Journal of cancer research and clinical oncology 2019 Aug . Deng Li-Li, Gao Ge, Deng Hong-Bin, Wang Feng, Wang Zhi-Hui, Yang |
| NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas. Cancer medicine 2019 Jun . Tlemsani Camille, Pécuchet Nicolas, Gruber Aurelia, Laurendeau Ingrid, Danel Claire, Riquet Marc, Le Pimpec-Barthes Françoise, Fabre Elizabeth, Mansuet-Lupo Audrey, Damotte Diane, Alifano Marco, Luscan Armelle, Rousseau Benoit, Vidaud Dominique, Varin Jennifer, Parfait Beatrice, Bieche Ivan, Leroy Karen, Laurent-Puig Pierre, Terris Benoit, Blons Helene, Vidaud Michel, Pasmant Er |
| Precision oncology of lung cancer: genetic and genomic differences in Chinese population. NPJ precision oncology 2019 3 14. Shen Hongbing, Zhu Meng, Wang Che |
| Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease markers 2019 2019 3837687. Kang Jingjing, Luo Yang, Wang Di, Men Yu, Wang Jianyang, Che Yi-Qun, Hui Zhougua |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Hayashi Takuo, Desmeules Patrice, Smith Roger S, Drilon Alexander, Somwar Romel, Ladanyi Ma |
| HER2 mutations in Chinese patients with non-small cell lung cancer. Oncotarget 2016 Aug . Song Zhengbo, Yu Xinmin, Shi Zhiyong, Zhao Jun, Zhang Yipi |
| Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Redig Amanda J, Capelletti Marzia, Dahlberg Suzanne E, Sholl Lynette M, Mach Stacy L, Fontes Caitlin, Shi Yunling, Chalasani Poornima, Janne Pasi |
| Chromosomal microarray provides enhanced targetable gene aberration detection when paired with next generation sequencing panel in profiling lung and colorectal tumors. Cancer genetics 2016 Jan . Mukherjee S, Ma Z, Wheeler S, Sathanoori M, Coldren C, Prescott J L, Kozyr N, Bouzyk M, Correll M, Ho H, Chandra P K, Lennon P |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: